Description

7-(5-(1,5-Dichloropentan-3-Yl)-1-Methyl-1H-Benzo[D]Imidazol-2-Yl)-n-Hydroxyheptanamide is a specialized, high-purity organic compound designed for advanced research and development applications. This molecule is valued for its role as a key synthetic intermediate and potential pharmacophore in the discovery of novel therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories, biotechnology companies, and academic research institutions focused on medicinal chemistry and drug discovery. The compound's specific structure makes it a critical building block for developing targeted inhibitors and probes.

Application

• Pharmaceutical Research & Development: Serves as a crucial synthetic intermediate in the discovery and development of new drug candidates, particularly for targeted therapies.
• Medicinal Chemistry Studies: Used as a core scaffold or pharmacophore for structure-activity relationship (SAR) studies to optimize biological activity and selectivity.
• Biochemical Probe Development: Acts as a starting material for creating specific enzyme inhibitors or receptor modulators used in mechanistic biological studies.
• Preclinical Development: Employed in the synthesis of compounds for in vitro and in vivo efficacy and toxicity testing during early-stage drug development.
• Academic Research: Utilized in university and institutional labs for cutting-edge research in organic synthesis, chemical biology, and pharmacology.
• Contract Research Organizations (CROs): Supplied to CROs supporting pharmaceutical and biotech clients with custom synthesis and screening services.

Basic Information

Product Name	7-(5-(1,5-Dichloropentan-3-Yl)-1-Methyl-1H-Benzo[D]Imidazol-2-Yl)-n-Hydroxyheptanamide
CAS No.	1236199-60-2
Molecular Formula	C20H27Cl2N3O2
Molecular Weight	412.35 g/mol
Synonyms	N-Hydroxy-7-[5-(1,5-dichloropentan-3-yl)-1-methyl-1H-benzimidazol-2-yl]heptanamide; 7-(5-(1,5-Dichloro-3-pentanyl)-1-methyl-1H-benzimidazol-2-yl)-N-hydroxyheptanamide; CAS 1236199-60-2; Hydroxamic acid derivative bearing benzimidazole; Benzimidazole-hydroxamate conjugate; HDAC inhibitor intermediate (potential); Research compound 1236199-60-2
EINECS	Contact for details

Quality Control

Every batch of 7-(5-(1,5-Dichloropentan-3-Yl)-1-Methyl-1H-Benzo[D]Imidazol-2-Yl)-n-Hydroxyheptanamide is manufactured and tested under a strict quality management system. Our products undergo rigorous analytical testing, including HPLC, NMR, and MS, to ensure high purity and identity confirmation, meeting the exacting standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and analytical methods is provided with each shipment to ensure full traceability and compliance with your research protocols.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a cool, dry, and well-ventilated place. Due to its sensitivity, the material should be stored under an inert atmosphere (e.g., nitrogen or argon) to prevent oxidation. Keep away from heat, sparks, and open flame.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.